Project lead Robyn Parsons explains how the UK National Haemoglobinopathy Reference Laboratory in Oxford has provided a dedicated sickle cell and thalassaemia laboratory support service for antenatal and newborn laboratories and other healthcare professionals involved in the NHS SCT Screening Programme since 2010.
NHS England has published the 2018 to 2019 service specifications - important reading for those involved in the commissioning and provision of screening services in England.
This year’s Royal College of Midwives (RCM) conference starts today in Manchester with more than 3,500 delegates attending. PHE Screening has a stand where we will be updating delegates on all the antenatal and newborn national screening programmes and answering any questions they may have.
The Screening tests for you and your baby: easy guides have been well received by health professionals and the public, an evaluation project has found.
Princess Royal University Hospital, in Kent, has made a very simple change that is having a big impact on improving early access to sickle cell and thalassaemia screening.
We've launched 3 e-learning modules aimed at our screening quality assurance service staff and the professional and clinical advisors who provide specialist expertise.
Information about replacing our credit card sized collection of plastic resource cards which support midwives in their conversations about screening with women and their families, to facilitate informed choices.
One of the main roles of Public Health England's (PHE) screening quality assurance service (SQAS) is to carry out formal visits to antenatal and newborn screening services. SQAS works with professional and clinical advisors when visiting laboratories providing screening tests for: …
Related content and links
The PHE Screening team
Public Health England (PHE) existed to protect and improve the nation’s health and wellbeing, and reduce health inequalities. It closed on 30 September 2021 and this blog is no longer updated.
